Germany
· Delayed Price · Currency is EUR Redcare Pharmacy NV Statistics
Total Valuation
FRA:RDC has a market cap or net worth of EUR 2.70 billion. The enterprise value is 2.79 billion.
| Market Cap | 2.70B |
| Enterprise Value | 2.79B |
Important Dates
The next estimated earnings date is Tuesday, May 6, 2025.
| Earnings Date | May 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +4.24% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 14.67M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.14 |
| PB Ratio | 5.29 |
| P/TBV Ratio | 37.12 |
| P/FCF Ratio | 201.60 |
| P/OCF Ratio | 121.93 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -61.43 |
| EV / Sales | 1.18 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 208.70 |
Financial Position
The company has a current ratio of 2.00, with a Debt / Equity ratio of 0.48.
| Current Ratio | 2.00 |
| Quick Ratio | 1.21 |
| Debt / Equity | 0.48 |
| Debt / EBITDA | n/a |
| Debt / FCF | 18.42 |
| Interest Coverage | -4.49 |
Financial Efficiency
Return on equity (ROE) is -8.73% and return on invested capital (ROIC) is -2.81%.
| Return on Equity (ROE) | -8.73% |
| Return on Assets (ROA) | -2.16% |
| Return on Invested Capital (ROIC) | -2.81% |
| Return on Capital Employed (ROCE) | -4.64% |
| Revenue Per Employee | 1.30M |
| Profits Per Employee | -24,885 |
| Employee Count | 1,827 |
| Asset Turnover | 2.34 |
| Inventory Turnover | 12.60 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -0.86% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -0.86% |
| 50-Day Moving Average | 123.84 |
| 200-Day Moving Average | 131.99 |
| Relative Strength Index (RSI) | 56.81 |
| Average Volume (20 Days) | 114,627 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, FRA:RDC had revenue of EUR 2.37 billion and -45.46 million in losses. Loss per share was -2.27.
| Revenue | 2.37B |
| Gross Profit | 545.78M |
| Operating Income | -34.95M |
| Pretax Income | -47.83M |
| Net Income | -45.46M |
| EBITDA | -12.83M |
| EBIT | -34.95M |
| Loss Per Share | -2.27 |
Balance Sheet
The company has 177.56 million in cash and 246.54 million in debt, giving a net cash position of -68.99 million.
| Cash & Cash Equivalents | 177.56M |
| Total Debt | 246.54M |
| Net Cash | -68.99M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 509.97M |
| Book Value Per Share | 23.79 |
| Working Capital | 250.29M |
Cash Flow
In the last 12 months, operating cash flow was 22.13 million and capital expenditures -8.74 million, giving a free cash flow of 13.38 million.
| Operating Cash Flow | 22.13M |
| Capital Expenditures | -8.74M |
| Free Cash Flow | 13.38M |
| FCF Per Share | n/a |
Margins
Gross margin is 23.02%, with operating and profit margins of -1.47% and -1.92%.
| Gross Margin | 23.02% |
| Operating Margin | -1.47% |
| Pretax Margin | -2.02% |
| Profit Margin | -1.92% |
| EBITDA Margin | -0.54% |
| EBIT Margin | -1.47% |
| FCF Margin | 0.56% |
Dividends & Yields
FRA:RDC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.24% |
| Shareholder Yield | -4.24% |
| Earnings Yield | -1.69% |
| FCF Yield | 0.50% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
FRA:RDC has an Altman Z-Score of 5.34.
| Altman Z-Score | 5.34 |
| Piotroski F-Score | n/a |